BioCorRx Completes Final Subject Enrollment in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

BioCorRx

BioCorRx Inc., a developer and provider of innovative treatment programs for substance abuse and related disorders, today announced that the last subject has been enrolled in the Phase I clinical trial of BICX104, an implantable biodegradable naltrexone pellet for the treatment of opioid use disorder.

Read full article

Researchers Developing Implant To Fight Alcohol, Opioid Addiction

Newsy

You might know Jeremy Miller from the ’80s family sitcom “Growing Pains.” But it’s the pains of addiction that he wants to share now. “Even on the show, I never had it together,” he said. Miller has a family medical history of alcohol use disorder on both sides. He began drinking at a very young age.

Watch full interview

‘Growing Pains’ star Jeremy Miller drank a ‘half pint of vodka’ and got a DUI during low point of addiction

Fox News

“Growing Pains” actor Jeremy Miller shared one of his rock bottom points of his battle with alcoholism from years ago when he was pulled over for driving under the influence after drinking a “half pint of vodka” and getting behind the wheel.

Listen to full interview

BioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day Podcast

Stock Day Media

The Stock Day Podcast welcomed BioCorRx Inc. (OTCQB: BICX)(“the Company”), an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. CEO and CFO of the Company, Lourdes Felix, joined Stock Day host Everett Jolly.

Listen to full interview

BioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day Podcast

Bloomberg

The Stock Day Podcast welcomed BioCorRx Inc. (OTCQB: BICX) (“the Company”), an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders. CEO and CFO of the Company, Lourdes Felix, joined Stock Day host Everett Jolly.

Read full article

OC firm fighting addiction seeks volunteers for clinical trial

The Orange County Register

Sure, you’ve heard that drug- and alcohol-related deaths soared during the pandemic, but the impact on children — who should be going to Scout meetings and soccer games, play practice and karate class — is truly stupefying. From 2019 to 2020 in Orange County, drug and alcohol deaths among kids aged 10-17 exploded by 800%. From 2020 to 2021, they shot up another 122%.

Read full article

Rewiring Your Medication

RadioMD

Edward Bowz, LMFT has an MA in Clinical Psychology from Phillips Graduate Institute and is the Director of Behavioral Health for BioCorRx®. He was the first mental health practitioner certified by BioCorRx to administer the BioCorRx Counseling Program consisting of their 35 Keys to Sobriety.

Listen to full interview

BioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104

BIOCORRX

BioCorRx Inc. today announced that the first subject has been dosed in the Phase I clinical trial of BICX104, an implantable biodegradable naltrexone pellet for the treatment of opioid use disorder (OUD), which is being developed under BioCorRx Pharmaceuticals, Inc., the Company’s controlled clinical stage pharmaceutical company.

Read full article

Listen to Tom’s Podcast!

CORUZANT TECHNOLOGIES

Tom Welch is Executive Vice President at BioCorRx. Mr. Welch has decades of operating experience and was a founder and Director of Operations at TAK Management from 2012 until 2015. Mr. Welch led a team that completely reorganized clinic operations. Tom also successfully negotiated reimbursement with major private insurance corporations across the U.S.

Listen to full podcast

June is PTSD Awareness Month

Tom Welch is interviewed on Fox News, representing BioCorRx’s latest efforts in new gamification therapy techniques using the MetaVerse. Watch the interview in full!

Removing the Addiction Barrier

CORUZANT TECHNOLOGIES

According to The National Health Study for a New Generation of United States Veterans — a large-scale VA health study of 60,000 Iraq and Afghanistan veterans — 13.5% of deployed and non-deployed service members screened positive for PTSD. Over 30% of these individuals reported self-medicating with drugs and alcohol, which mental health professionals note exacerbates PTSD and creates barriers to its treatment.

Read full article

BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting

BIOCORRX

Collaboration to create a synergistic treatment offering, combining BioCorRx’s MAT treatment program and 2B3D virtual reality technology. Plans toward expanding the offering to other at-risk groups upon evaluating results of pilot with veterans.

Read full article

First Trials Set to Begin for BICX104, An Unprecedented Way for Patients to Receive Naltrexone

ENTREPRENEUR MAGAZINE

According to the CDC, there were 75,673 opioid-related overdose deaths from April 2020 to April 2021, a near 20,000 increase from the 12-month period prior… But the latest news from addiction treatment solutions company BioCorRx could change the way patients and treatment providers approach the process of recovery forever.

Read full article

Stay Immersed In Your Market Plan

MED TECH GURUS

In this episode, we have Ms. Lourdes Felix Chief Executive Officer and Director of BioCorRx and President of BioCorRx Pharmaceuticals Inc. Gurus Lourdes takes us down the path of why being immersed in a market plan pays huge dividends for you and ultimately the patients you help.

Listen to full interview

BioCorRx Provides Update on R&D Candidates, Mental Health Awareness and Clinical Development

SNN Network

BioCorRx Inc. (OTCQB: BICX) is an addiction treatment solutions company offering a unique approach to the treatment of substance use and other related disorders.

Watch full interview

Tom Welch Podcast Interview

HERE’S TO YOUR HEALTH WITH JOSHUA LANE

Our guest this morning is Tom Welch and Tom Welch is the Executive Vice President of BioCorRx and they are a leading healthcare solutions company and they focus on improving the lives of those struggling with alcohol, opioid and other addictive disorders.

Read more

This new treatment may cure addiction .. any addiction

WSB-TV

A medical implant containing a time-released drug that attacks cravings from opiates, heroin and alcohol helped a local businessman break a $9,000 per month addiction to pain medication.

Read more

A year into Biden’s presidency, we’re only burying more overdose victims

THE HILL

In 1999, there were just under 20,000 fatal overdoses. Now, overdose deaths are five times higher—over 100,000 in the 12 months ending May 2021, according to the CDC’s most recent, tragically delayed, data.

Read more

The Pandemic Has Aggravated the Opioid Crisis – Is Biden’s Plan Enough to Combat It?

PHARMALIVE

The pandemic has undoubtedly altered the way of life for all Americans, but it has also shed light into the bleak statistics that are showing the opioid crisis is even worse than ever before.

Read more

‘Saved our son’s life’ — injectable pellet, fentanyl vaccine among cutting-edge addiction treatments

NEWS 5 CLEVELAND

With recent news of record-breaking drug overdose deaths across the country and in our own backyards, News 5 Investigators went searching for the cutting edge strategies in this battle against drugs.

Read more

A New Bill in Congress Designates Methamphetamines as an Emerging Threat, but is it enough?

BeatAddiction News

At an alarming pace, Meth is gaining ground on opioids as an addictive substance. Solutions could lie in some of Ohio’s recent efforts. Michael Howcroft, Pharmacy Consultant, Beat Addiction Recovery.

Read more